A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.
Saved in:
| Title: | A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. |
|---|---|
| Authors: | El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Lieu CH; University of Colorado Cancer Center, Aurora, CO, USA., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College at Cornell University, New York, NY, USA.; Trinity College Dublin, Dublin, Ireland., Tsimberidou AM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahadevan D; The University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA., Hanna DL; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Bockorny B; Beth Israel Deaconess Medical Center, Boston, MA, USA., Wilky BA; University of Colorado Cancer Center, Aurora, CO, USA., Leal A; University of Colorado Cancer Center, Aurora, CO, USA., Stebbing J; Anglia Ruskin University, Cambridge, UK., Avagyan M; Agenus Inc, Lexington, MA, USA., Wu W; Agenus Inc, Lexington, MA, USA., Chand D; Agenus Inc, Lexington, MA, USA., Grossman JE; Agenus Inc, Lexington, MA, USA., Johnson B; Agenus Inc, Lexington, MA, USA., Bullock AJ; Beth Israel Deaconess Medical Center, Boston, MA, USA. |
| Source: | Liver cancer [Liver Cancer] 2026 Mar 30. Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42131624 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lieu+CH%22">Lieu CH</searchLink>; University of Colorado Cancer Center, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Medical College at Cornell University, New York, NY, USA.; Trinity College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Tsimberidou+AM%22">Tsimberidou AM</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mahadevan+D%22">Mahadevan D</searchLink>; The University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hanna+DL%22">Hanna DL</searchLink>; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bockorny+B%22">Bockorny B</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wilky+BA%22">Wilky BA</searchLink>; University of Colorado Cancer Center, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Leal+A%22">Leal A</searchLink>; University of Colorado Cancer Center, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Stebbing+J%22">Stebbing J</searchLink>; Anglia Ruskin University, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Avagyan+M%22">Avagyan M</searchLink>; Agenus Inc, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Agenus Inc, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chand+D%22">Chand D</searchLink>; Agenus Inc, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Grossman+JE%22">Grossman JE</searchLink>; Agenus Inc, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+B%22">Johnson B</searchLink>; Agenus Inc, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bullock+AJ%22">Bullock AJ</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101597993%22">Liver cancer</searchLink> [Liver Cancer] 2026 Mar 30. <i>Date of Electronic Publication: </i>2026 Mar 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597993 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2235-1795 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216645553%22">16645553 </searchLink><i>NLM ISO Abbreviation: </i>Liver Cancer |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42131624 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000551630 Languages: – Code: eng Text: English Titles: – TitleFull: A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: El-Khoueiry AB – PersonEntity: Name: NameFull: Lieu CH – PersonEntity: Name: NameFull: Abou-Alfa GK – PersonEntity: Name: NameFull: Tsimberidou AM – PersonEntity: Name: NameFull: Mahadevan D – PersonEntity: Name: NameFull: Hanna DL – PersonEntity: Name: NameFull: Bockorny B – PersonEntity: Name: NameFull: Wilky BA – PersonEntity: Name: NameFull: Leal A – PersonEntity: Name: NameFull: Stebbing J – PersonEntity: Name: NameFull: Avagyan M – PersonEntity: Name: NameFull: Wu W – PersonEntity: Name: NameFull: Chand D – PersonEntity: Name: NameFull: Grossman JE – PersonEntity: Name: NameFull: Johnson B – PersonEntity: Name: NameFull: Bullock AJ IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 03 Text: 2026 Mar 30 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2235-1795 Titles: – TitleFull: Liver cancer Type: main |
| ResultId | 1 |